As of 2025-09-18, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is 18.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.59 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is 63.8%.
The range of the Relative Valuation is 15.67 - 21.58 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 22.9x | 22.3x |
| Forward P/E multiples | 19.8x - 26.1x | 23.7x |
| Fair Price | 15.67 - 21.58 | 18.99 |
| Upside | 35.2% - 86.2% | 63.8% |
| Date | P/E |
| 2025-09-15 | 14.46 |
| 2025-09-12 | 14.68 |
| 2025-09-11 | 14.73 |
| 2025-09-10 | 14.27 |
| 2025-09-09 | 14.47 |
| 2025-09-08 | 14.75 |
| 2025-09-05 | 15.64 |
| 2025-09-04 | 15.51 |
| 2025-09-03 | 15.30 |
| 2025-09-02 | 14.95 |
| 2025-08-29 | 14.60 |
| 2025-08-28 | 14.97 |
| 2025-08-27 | 14.96 |
| 2025-08-26 | 15.31 |
| 2025-08-25 | 14.83 |
| 2025-08-22 | 14.95 |
| 2025-08-21 | 13.92 |
| 2025-08-20 | 14.25 |
| 2025-08-19 | 13.91 |
| 2025-08-18 | 13.91 |
| 2025-08-15 | 14.89 |
| 2025-08-14 | 14.20 |
| 2025-08-13 | 14.69 |
| 2025-08-12 | 13.98 |
| 2025-08-11 | 12.50 |
| 2025-08-08 | 13.27 |
| 2025-08-07 | 13.28 |
| 2025-08-06 | 13.79 |
| 2025-08-05 | 13.59 |
| 2025-08-04 | 13.71 |
| 2025-08-01 | 13.99 |
| 2025-07-31 | 13.96 |
| 2025-07-30 | 14.67 |
| 2025-07-29 | 14.21 |
| 2025-07-28 | 14.31 |
| 2025-07-25 | 14.03 |
| 2025-07-24 | 14.82 |
| 2025-07-23 | 14.85 |
| 2025-07-22 | 15.77 |
| 2025-07-21 | 13.93 |
| 2025-07-18 | 12.11 |
| 2025-07-17 | 11.76 |
| 2025-07-16 | 11.24 |
| 2025-07-15 | 11.23 |
| 2025-07-14 | 11.27 |
| 2025-07-11 | 11.18 |
| 2025-07-10 | 11.48 |
| 2025-07-09 | 11.18 |
| 2025-07-08 | 11.23 |
| 2025-07-07 | 10.39 |